Non-gastric extra-nodal marginal zone lymphomas - A single centre experience on 76 patients

Leukemia and Lymphoma

Volumn 49, Issue 12, 2008, Pages 2308-2315

  Kalpadakis, Christina ^b   Pangalis, Gerassimos A ^b   Vassilakopoulos, Theodoros A ^b   Kyrtsonis, Maria Christina ^b   Siakantaris, Marina P ^b   Kontopidou, Flora N ^b   Korkolopoulou, Penelope ^b   Bobotsis, Panagia ^b   Sahanas, Sotirios ^b   Tzenou, Tatiana ^b   Anagnostou, Dimitra ^b   Dimitriadou, Evangelia ^b   Yiakoumis, Xanthi ^b   Patsouris, Evangelos ^b   Roussou, Panagiota ^b   Panayiotidis, Panayiotis ^b   Papadaki, Eleni ^a   Angelopoulou, Maria K ^b  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Extranodal marginal zone lymphoma; Lymphoma; MALT

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CORTICOSTEROID; RITUXIMAB;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW CANCER; CANCER LOCALIZATION; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG RESPONSE; EYE CANCER; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE LYMPHOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SALIVARY GLAND CANCER; SKIN LYMPHOMA; SURVIVAL RATE; SURVIVAL TIME; WALDEYER RING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHLORAMBUCIL; FEMALE; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57449112065     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802510331     Document Type: Article

References (52)

1. Isaacson, P. (1999) Mucosa-associated lymphoid tissue lymphoma. Semin Hematol, 36, pp. 139-147.
2. Cavali, F., Isaacson, P. G., Gascoyne, R. D. and Zucca, E. (2001) MALT lymphomas. Hematology (Am Soc Hematol Educ Program), 1, pp. 241-258.
3. Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K. Vardiman, J. et al. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, pp. 1361-1392.
4. Isaacson, P. G., Muller-Hermelink, H. K., Piris, M. A., Berger, F., Nathwani, B. N. Swerdlow, S. H. et al. (2001) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours, pp. 157-160. IARC Press, Lyon, France
5. Drillenburg, P., van der Voort, R., Koopman, G., Dragosics, B., van Krieken, J. H. Kluin, P. et al. (1997) Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol, 150, pp. 919-927.
6. Dogan, A., Du, M., Koulis, A., Briskin, M. J. and Isaacson, P. G. (1997) Expression of lymphocyte homing receptors and vascular addressing in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol, 151, pp. 1361-1369.
7. Drillenburg, P. and Pals, S. T. (2000) Cell adhesion receptors in lymphoma dissemination. Blood, 95, pp. 1900-1910.
8. Nathwani, B. N., Anderson, J. R., Armitage, J. O., Cavalli, F., Diebold, J. Drachenberg, M. R. et al. (1999) Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol, 17, pp. 2486-2492.
9. Isaacson, P. (1992) Extranodal lymphomas: The MALT concept. Verh Dtsch Ges Pathol, 76, pp. 14-23.
10. Zucca, E., Bertoni, F., Roggero, E. and Cavalli, F. (2000) The gastric marginal zone B-cell lymphoma of MALT type. Blood, 96, pp. 410-419.
11. Wotherspoon, A. C., Ortiz-Hidalgo, C., Falzon, M. R. and Isaacson, P. G. (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338, pp. 1175-1176.
12. Du, M. Q. and Isaccson, P. G. (2002) Gastric MALT lymphoma: From aetiology to treatment. Lancet Oncol, 3, pp. 97-104.
13. Wotherspoon, A. C., Doglioni, C., Diss, T. C., Pan, L., Moschini, A. de Boni, M. et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 342, pp. 575-577.
14. Thieblemont, C., Berger, F., Dumontet, C., Moullet, I., Bouafia, F. Felman, P. et al. (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood, 95, pp. 802-806.
15. Zucca, E., Conconi, A., Pedrinis, E., Cortelazzo, S., Motta, T. Gospodarowicz, M. K. et al. (2003) International Extranodal Lymphoma Study Group. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood, 101, pp. 2489-2495.
16. Raderer, M., Wohrer, S., Streubel, B., Troch, M., Turetschek, K. Jager, U. et al. (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: A single-center experience. J Clin Oncol, 24, pp. 3136-3141.
17. Zinzani, P. L., Magagnoli, M., Galieni, P., Martelli, M., Poletti, V. Zaja, F. et al. (1999) Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: Analysis of 75 patients. J Clin Oncol, 17, pp. 1254-1258.
18. Arcaini, L., Burcheri, S., Rossi, A., Passamonti, F., Paulli, M. Boveri, E. et al. (2006) Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination. The Oncologist, 11, pp. 285-291.
19. Thieblemont, C., Bastion, Y., Berger, F., Rieux, C., Salles, G. Dumontet, C. et al. (1997) Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: Analysis of 108 patients. J Clin Oncol, 15, pp. 1624-1630.
20. Streubel, B., Simonitsch-Klupp, I., Mullauer, L., Lamprecht, A., Huber, D. Siebert, R. et al. (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia, 18, pp. 1722-1766.
21. The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, pp. 3909-3918.
22. Kurtin, P. J., Myers, J. L., Adlakha, H., Strickler, J. G., Lohse, C. Pankratz, V. S. et al. (2001) Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surgical Pathol, 25, pp. 997-1008.
23. Wenzel, C., Fiebiger, W., Dieckmann, K., Formanek, M., Chott, A. and Raderer, M. (2003) Extranodal marginal zone B-cell lymphoma tissue of the head and neck area. Cancer, 97, pp. 2236-2241.
24. Cahill, M., Barnes, C., Moriarty, P., Daly, P. and Kennedy, S. (1999) Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br J Ophthalmol, 83, pp. 742-747.
25. Servitje, O., Gallardo, F., Estrach, T., Pujol, R. M., Blanco, A. Fernandez-Sevilla, A. et al. (2002) Primary cutaneous marginal zone B-cell lymphoma: A clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol, 147, pp. 1147-1158.
26. Isaacson, P. G., Banks, P. M., Best, P. V., McLure, S. P., Muller-Hermelink, H. K. and Wyatt, J. I. (1995) Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type. Am J Surg Pathol, 19, pp. 571-575.
27. Parveen, T., Navarro-Roman, L., Medeiros, L. J., Raffeld, M. and Jaffe, E. S. (1993) Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the kidney. Arch Pathol Lab Med, 117, pp. 780-783.
28. Ansell, S. M., Grant, C. S. and Habermann, T. M. (1999) Primary thyroid lymphoma. Semin Oncol, 26, pp. 316-323.
29. Zucca, E., Roggero, E., Bertoni, F., Conconi, A. and Cavalli, F. (1999) Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol, 10, pp. 1023-1033.
30. Zucca, E., Roggero, E., Bertoni, F. and Cavalli, F. (1997) Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol, 8, pp. 727-737.
31. Hyjek, E. and Isaacson, P. (1988) Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol, 19, pp. 1315-1326.
32. Diss, T. C., Wotherspoon, A. C., Speight, P., Pan, L. and Isaacson, P. G. (1995) B-cell monoclonality, Epstein Barr virus, and t(14;18) in myoepithelial sialadenitis and low grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol, 19, pp. 531-536.
33. Ambrosetti, A., Zanotti, R., Pattaro, C., Lenzi, L., Chilosi, M. Caramaschi, P. et al. (2004) Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjogren syndrome or hepatitis C virus infenction. Br J Haematol, 126, pp. 43-49.
34. Royer, B., Cazals-Hatem, D., Sibilia, J., Agbalika, F., Cayuela, J. M. Soussi, T. et al. (1997) Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood, 90, pp. 766-775.
35. Ferreri, A. J., Guidoboni, M., Ponzoni, M., De Conciliis, C., Dell'Oro, S. Fleischhauer, K. et al. (2004) Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst, 96, pp. 586-594.
36. Rosado, M. F., Byrne Jr, G. E., Ding, F., Fields, K. A., Ruiz, P. Dubovy, S. R. et al. (2006) Ocular adnexal lymphoma: A clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood, 107, pp. 467-472.
37. Cerroni, L., Zochling, N., Putz, B. and Kerl, H. (1997) Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol, 24, pp. 457-461.
38. Roggero, E., Zucca, E., Mainetti, C., Bertoni, F., Valsangiacomo, C. Pedrinis, E. et al. (2000) Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol, 31, pp. 263-268.
39. Luppi, M., Longo, G., Ferrari, M. G., Ferrara, L., Marasca, R. Barozzi, P. et al. (1996) Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol, 94, pp. 373-375.
40. Ascoli, V., Lo Coco, F, Artini, M., Levrero, M., Martelli, M. and Negro, F. (1998) Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol, 109, pp. 600-609.
41. Zucca, E., Roggero, E., Maggi-Solca, N., Conconi, A., Bertoni, F. Reilly, I. et al. (2000) Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica, 85, pp. 147-153.
42. Lecuit, M., Abachin, E., Martin, A., Poyart, C., Pochart, P. Suarez, F. et al. (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med, 350, pp. 239-248.
43. Raderer, M., Vorbeck, F., Formanek, M., Osterreicher, C., Valencak, J. Penz, M. et al. (2000) Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer, 83, pp. 454-457.
44. de Boer, J. P., Hiddink, R. F., Raderer, M., Antonini, N., Aleman, B MP Boot, H. et al. (2008) Dissemination patterns in non-gastric MALT lymphoma. Haematologica, 93, pp. 201-206.
45. Thieblemont, C. (2005) Clinical presentation and management of marginal zone lymphoma. Hematology (Am Soc Hematol Educ Program), 1, pp. 307-313.
46. Ahmed, S., Kussick, S., Siddiqui, A., Bhuiya, T., Khan, A. Sarewitz, S. et al. (2004) Bronchial-associated lymphoid tissue lymphoma: A clinical study of a rare disease. Eur J Cancer, 40, pp. 1320-1326.
47. Siakantaris, M. P., Gonis, N. K., Angelopoulou, M. K., Kourtis, I., Kontopidou, F. N. Dimopoulou, M. N. et al. (2000) Low grade gastric MALT lymphoma (LGGMALT) clinical stage I. A seemingly localized disease. Blood, 96, p. 329a.
48. Raderer, M., Streubel, B., Woehrer, S., Puespoek, A., Jaeger, U. Formanek, M. et al. (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res, 11, pp. 3349-3352.
49. Conconi, A., Martinelli, G., Thieblemont, C., Ferreri, A. J., Devizzi, L. Peccatori, F. et al. (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood, 102, pp. 2741-2745.
50. Kalpadakis, C., Pangalis, G. A., Dimopoulou, M., Vassilakopoulos, T. P., Kyrtsonis, M. C. Korkolopoulou, P. et al. (2007) Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Heamatol Oncol, 25, pp. 107-114.
51. Kyrtsonis, M., Siakantaris, M. P., Kalpadakis, C., Dimopoulou, M. N., Vassilakopoulos, T. P. Kontopidou, F. N. et al. (2006) Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab. Eur J Haematol, 77, pp. 300-303.
52. Boussiotis, V. A., Panayiotidis, P. G. and Pangalis, G. A. (1991) Prolonged intermittent chlorambucil administration in B-chronic lymphocytic leukemia: Experience from a single haematology Unit. Leuk Lymphoma, 5, pp. 113-118.